Related Experiment Video
Updated: Apr 27, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Evaluation of the impact of a pertussis cocooning program on infant pertussis infection
C Mary Healy1, Marcia A Rench, Susan H Wootton
1From the *Department of Pediatrics, Baylor College of Medicine; †Ben Taub General Hospital; ‡Center for Vaccine Awareness and Research, Texas Children's Hospital; and §University of Texas Health Sciences Center at Houston, Houston, TX.
Insights
Cocooning programs, involving tetanus, diphtheria, and acellular pertussis (Tdap) immunization of infant contacts, did not reduce severe pertussis in young infants. Increased Tdap immunization during pregnancy is recommended to prevent infant pertussis.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Infant pertussis poses a significant health risk.
- The Centers for Disease Control and Prevention recommends cocooning (immunizing infant contacts) to prevent pertussis.
- The effectiveness of cocooning programs in reducing severe infant pertussis needed evaluation.
Purpose of the Study:
- To determine if implementing a cocooning program at Ben Taub General Hospital reduced severe pertussis in infants.
- To assess the impact of postpartum and cocooning immunization strategies on infant pertussis.
Main Methods:
- A comparative study design was used, comparing infants diagnosed with pertussis before and after the implementation of cocooning.
- Infants ≤6 months diagnosed with pertussis were identified using ICD-9 codes and microbiology records.
- Data were collected from four hospitals, comparing infants born during preintervention, postpartum (PP), and cocooning (C) periods.
Main Results:
- A total of 196 infants were diagnosed preintervention, 140 during PP, and 64 during C.
- Infant demographics, age at diagnosis, hospitalization rates, and outcomes were similar across periods, except for a significant increase in intensive care unit admissions during the cocooning period (68%).
- No significant reduction in pertussis illness or mortality was observed with postpartum or cocooning immunization strategies.
Conclusions:
- Postpartum immunization and cocooning strategies did not effectively reduce pertussis illness in infants ≤6 months.
- Increased tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy, combined with cocooning, is suggested to better prevent severe infant pertussis.
- Further research and implementation strategies are needed to enhance Tdap coverage in pregnant women.
Background:
Tetanus, diphtheria and acellular pertussis immunization of infant contacts (cocooning) is recommended by the Centers for Disease Control and Prevention to prevent infant pertussis. We determined whether implementing a cocooning program at Ben Taub General Hospital, Houston, reduced severe pertussis in young infants.
Methods:
Infants ≤6 months of age, diagnosed with pertussis (determined by International Classification of Diseases, Ninth Revision codes and microbiology records) at 4 hospitals, and born at times when only postpartum women (January 2008 through May 2009) and all infant contacts (June 2009 through August 2011) were offered tetanus, diphtheria and acellular pertussis vaccine at Ben Taub General Hospital were compared with infants born preintervention (May 2004 through December 2007).
Results:
One hundred ninety-six (49%) infants with pertussis were born preintervention, 140 (35%) during maternal postpartum (PP) and 64 (16%) during cocooning (C) periods. Infants were similar in age at diagnosis (81.2 vs. 71.3 [PP] vs. 72.5 [C] days; P 0.07), sex (male 59% vs. 51% [PP] vs. 48% [C]; P 0.17), hospitalization (68% vs. 71% [PP] vs. 78% [C]; P 0.27) and outcome (2 deaths in the PP period; P 0.15), but more were admitted to intensive care units during cocooning (24% vs. 35% [PP] vs. 68% [C]; P < 0.001). Similar proportions of infants were born at Ben Taub General Hospital throughout the study (8% vs. 9% [PP] vs. 5% [C]; P 0.53).
Conclusions:
Postpartum immunization and cocooning did not reduce pertussis illness in infants ≤6 months of age. Efforts should be directed toward increasing tetanus, diphtheria and acellular pertussis immunization during pregnancy, combined with cocooning, to reduce life-threatening young infant pertussis.
More Related Videos
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pneumonia II: Pathophysiology